Biodegradable Polycaprolactone/Polyethylene Glycol/Chitosan
Intravaginal Implants for Progesterone Delivery: A Preliminary Study
on Physicochemical Properties, Release Kinetics, and
Biocompatibility
1Research
Center for Animal Husbandry, National Research and Innovation Agency
(BRIN), Cibinong, Bogor, West Java, 16911, Indonesia; 2Research
Center for Advanced Material, National Research and Innovation
Agency (BRIN), Jakarta, 10340, Indonesia; 3Division of
Surgery and Radiology, School of Veterinary Medicine and Biomedical
Sciences, IPB University, Kampus IPB Dramaga, Bogor, West Java,
16680, Indonesia; 4Veterinary Pharmacy Sub Division,
School of Veterinary Medicine and Biomedical Sciences, IPB
University, Bogor 16680, Indonesia; 5Department of
Biomedical Engineering and Health Sciences, Faculty of Electrical
Engineering, Universiti Teknologi Malaysia, 81310 UTM Johor Bahru,
Johor, Malaysia; 6IJN-UTM Cardiovascular Engineering
Centre, Institute of Human Centered Engineering, Universiti
Teknologi Malaysia, 81310 UTM Johor Bahru, Johor, Malaysia; 7Division
of Reproduction and Obstetrics, School of Veterinary Medicine and
Biomedical Sciences, IPB University, Bogor, West Java, 16680,
Indonesia
The need for sustainable intravaginal drug-delivery systems in veterinary
reproduction is increasing day by day. However, most intravaginal devices
currently available in the market rely on non-biodegradable polymers. The aim of
this study was to develop and evaluate biodegradable progesterone implants
composed of polycaprolactone (PCL), polyethylene glycol (PEG) and chitosan.
Three formulations (10/72/18, 20/64/16 and 30/56/14% PCL/PEG/chitosan) were
fabricated via melt molding and characterized for morphology, mechanical
strength, degradation in simulated vaginal fluid (SVF), progesterone release,
cytocompatibility, and environmental compost biodegradation. Statistical
analysis was conducted using ANOVA followed, by Tukey’s post-hoc test to
identify significant differences among implant formulations. Implant I
(10/72/18% PCL/PEG/chitosan) demonstrated the highest porosity (11.9%; P<0.05),
fastest degradation (23% remaining after 10 days of immersion in SVF; P<0.05),
and a favourable biphasic progesterone release profile with excellent HeLa cell
viability (73% after 24h exposure; P<0.05). Implant II (20/64/16% PCL/PEG/chitosan)
showed steady progesterone release, whereas Implant III (30/56/14% PCL/PEG/chitosan)
exhibited an initial burst, followed by prolonged retention. In compost,
degradation ranged from complete fragmentation (Implant I) to minimal change
(Implant III) after 40 days of burial in compost (P<0.05). Preliminary in
vivo evaluation in four prepubertal
Friesian Holsteincyclic heifers
confirmed that Implant I was stable, non-inflammatory, and capable of
elevating plasma progesterone levels to physiological levels. In conclusion,
PCL/PEG/chitosan-based intravaginal system (10/72/18% PCL/PEG/chitosan) is
promising biodegradable platform for controlled veterinary hormone delivery and
might have potential applications in estrus synchronization in domestic animals.
To Cite This Article: Yessa EY, Santoso, Herdis, Aisah N, Herdianto N,
Sitaresmi PI, Gunanti, Wientarsih I, Noviana D, Saidin S, Purwantara B, Amrozi
and Ulum MF, 2026. Biodegradable polycaprolactone/polyethylene
glycol/chitosan intravaginal implants for progesterone delivery: a preliminary
study on physicochemical properties, release kinetics, and biocompatibility. Pak
Vet J. http://dx.doi.org/10.29261/pakvetj/2026.003